ADMS
Adamas Pharmaceuticals, Inc.
ADMS
ADMS
Delisted
ADMS was delisted on the 23rd of November, 2021.
97 hedge funds and large institutions have $207M invested in Adamas Pharmaceuticals, Inc. in 2018 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 41 increasing their positions, 26 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
97
Holders Change
-28
Holders Change %
-22.4%
% of All Funds
2.16%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.02%
New
14
Increased
41
Reduced
26
Closed
41
Calls
$2.47M
Puts
$462K
Net Calls
+$2.01M
Net Calls Change
-$17K
Top Buyers
| 1 |
BC
Broadfin Capital
New York
|
+$11M |
| 2 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$7.88M |
| 3 |
AC
Armistice Capital
New York
|
+$5.62M |
| 4 |
Morgan Stanley
New York
|
+$4.32M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
+$3.24M |
Top Sellers
| 1 |
Janus Henderson Group
London,
United Kingdom
|
-$18.2M |
| 2 |
State Street
Boston,
Massachusetts
|
-$12.3M |
| 3 |
AAP
Ardsley Advisory Partners
Stamford,
Connecticut
|
-$10.2M |
| 4 |
PA
Perceptive Advisors
New York
|
-$8.45M |
| 5 |
SI
Sofinnova Investments
Menlo Park,
California
|
-$6.92M |
